Results 61 to 70 of about 48,914 (162)

Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity. [PDF]

Arterioscler Thromb Vasc Biol
Hammond ST, Brandt L, Kong AL, White SB, Lewandowski D, Beyer AM.   +5 more
europepmc   +1 more source

Postoperative adjuvant eribulin in high-risk patients with soft tissue sarcoma: A retrospective study of eight cases. [PDF]

Rare Tumors
Murayama Y, Ideta H, Nakagawa R, Sukawa Y, Takahashi M, Kawashima H, Kikuta K.   +6 more
europepmc   +1 more source

Cardiac Surveillance for Anthracycline Cardiotoxicity: Clinical Yield in Low-to-Intermediate Risk Patients: MATRIX Study. [PDF]

JACC CardioOncol
Moreno-Arciniegas A, Gómez-Talavera S, Navarro-Guzman A, Galán-Arriola C, Ramos-Cillán S, Morillo D, Pardo L, Pérez-Sáenz MA, Córdoba R, Mass V, Escalera N, Fuster V, López-Fernández T, Sánchez-González J, Ibáñez B.   +14 more
europepmc   +1 more source

Refining the Role of ERK Signaling in Anthracycline-Induced Cardiotoxicity. [PDF]

JACC CardioOncol
Wang Z, Zhao D.
europepmc   +1 more source

Effects of Semaglutide in Doxorubicin-Induced Cardiac Toxicity in Wistar Albino Rats

Cancer Management and Research
Raz Muhammed HamaSalih Department of Pharmacology and Toxicology, College of Pharmacy, University of Sulaimani, Slemani, Kurdistan Region, IraqCorrespondence: Raz Muhammed HamaSalih, College of Pharmacy, University of Sulaimani, Town Campus, Slemani ...
HamaSalih RM
doaj  

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity. [PDF]

Front Cardiovasc Med
Pala B, Piscione M, Di Marcantonio MC, Cribari F, Vitale R, Baldi T, Popolo A, Mincione G.   +7 more
europepmc   +1 more source

Correction. [PDF]

JACC CardioOncol
europepmc   +1 more source

Supportive care challenges in a resource limited oncology setting: prevalence and management of anthracycline and vinca alkaloid extravasation in Sudan. [PDF]

BMC Cancer
Alzahman AR, Hamadalneel YB, Yousef BA, Mustafa MA, Alnazeer MH, Elhag EAA.   +5 more
europepmc   +1 more source

Review on cardioprotective strategies in the setting of chemotherapy-induced cardiotoxicity. [PDF]

Cardiooncology
Dao V, Amin S, Kammaripalle T, Manning K.   +3 more
europepmc   +1 more source

Sodium-Glucose Cotransporter-2 Inhibitors in Anthracycline-Treated Cancer Patients: A Narrative Review of Emerging Cardioprotective Evidence. [PDF]

Cureus
Nabhan E, Vana AP, Khouri R, Naoum Nehme E, Poulos N.   +4 more
europepmc   +1 more source